Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 1446-1453, October 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silagi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silagi, S.

Metabolism of 1-ß-D-Arabinofuranosylcytosine in L Cells1

Selma Silagi2

The Rockefeller Institute, New York, New York

1-ß-D-Arabinofuranosylcytosine inhibits mitosis and DNA3 synthesis, but not RNA or protein synthesis in mouse fibroblasts. This inhibition is irreversible in normal culture medium after treatment for as little as 2 hr with 10 µg/ml. Most cells die, and the survivors become grossly enlarged. Deoxycytidine, at concentrations 10–100 times as great, can prevent this lethal effect for a time and, within certain limits, partially reverse it; but deoxycytidine itself proves inhibitory with prolonged incubation.

Ara-C ultimately produces typical toxic effects in L cells even in the presence of deoxycytidine in large concentration. Ara-C is incorporated into DNA, and to a lesser extent into RNA. Replication of reovirus, a double-stranded RNA virus, is not inhibited by ara-C. It is postulated that the lethal effect of ara-C and its inhibition of continued DNA synthesis may be the result of its incorporation into DNA. This would probably result in configurational changes in a small region of helical DNA, with consequent failure of replication.

1 Supported in part by Contract GM 10717, USPHS grant, NIH.

3 The abbreviations used are: ara-C, 1-ß-D-arabinofuranosylcytosine; ara-U, 1-ß-D-arabinofuranosyluracil; CR, cytidine; CdR, deoxycytidine; CDP, cytidine diphosphate; dCDP, deoxycytidine diphosphate; dCTP, deoxycytidine triphosphate IUDR, 5-iodo-2'-deoxyuridine; FUDR, fluorodeoxyuridine; RNA, ribonucleic acid; DNA, deoxyribonucleic acid; DNase, deoxyribonuclease; TCA, trichloroacetic acid; Tris, tris (hydroxymethyl) aminomethane; L cells, mouse fibroblasts.

2 Present address: Division of Human Genetics, Department of Pedriatrics, Cornell University Medical College, New York, New York.

Received 1/11/65. Revised 5/ 6/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.